Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +40.12%
#2 aelf aelf +31.86%
#3 Bitway Bitway +30.02%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.94%
#5 Pons Pons +23.34%
#6 Starpower Starpower +22.55%
#7 Decred Decred +14.50%
#8 PondCoin PondCoin +10.22%
#9 Talus Network Talus Network +9.61%
#10 DAPPOS DAPPOS +8.37%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Perseus Proteomics Inc. Perseus Proteomics Inc.

Perseus Proteomics Inc.

4882
Rang in aandelen #30437
Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology... Based in Tokyo, Japan, Perseus Proteomics Inc. operates as a biotechnology venture specializing in the development of antibody-based therapeutics for various ailments, including cancer. Its core operations encompass pioneering antibody discovery, alongside providing extensive research support services. These services include hybridoma antibody sequencing, the production of antibody proteins, and undertaking contract antibody research projects. Furthermore, Perseus Proteomics supplies its own antibody products to the market. The company boasts a robust development pipeline featuring several promising candidates: PPMX-T001, an antibody targeting hepatocarcinoma; PPMX-T002, an oncology therapeutic; PPMX-T003, designed for the treatment of adult T-cell leukemia/lymphoma; and PPMX-T004, an innovative antibody-drug conjugate. Established in 2001, the firm maintains its headquarters in the Japanese capital.
Aandeelprijs
$0.92646056
Marktkapitalisatie
$17.07M
Verandering (1 dag)
-2.07%
Verandering (1 jaar)
-62.74%
Land
JP
Handel Perseus Proteomics Inc. (4882)

Categorie

Healthcare
P/B-ratio voor Perseus Proteomics Inc. (4882)
P/B-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Perseus Proteomics Inc. is de huidige P/B-ratio (TTM) 0. Eind 2026 had het bedrijf een P/B-ratio van 0.
P/B-ratiohistoriek voor Perseus Proteomics Inc. van 2026 tot 2026
P/B-ratio aan het einde van elk jaar
Jaar P/B-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/B-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/B-ratio Verschil in P/B-ratio Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.008 -
US